Phenotypic and clinical manifestations of compound heterozygous genetic haemochromatosis (CHGH): A non-invasive approach to clinical management

Internal Medicine Journal

Volumn 43, Issue 3, 2013, Pages 254-261

  Ramakrishna, R ^a,b   Gupta, S ^a   Sarathy, K ^a   Bowen, A ^c  

^a Southern Sydney Haematology   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c Southern IML Pathology   (Australia)

Author keywords

Compound heterozygous genetic haemochromatosis; Management algorithm; Phenotypic manifestation

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; GLUCOSE; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; COMPOUND HETEROZYGOUS GENETIC HEMOCHROMATOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GLUCOSE BLOOD LEVEL; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; HYPERFERRITINEMIA; IRON BLOOD LEVEL; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PHENOTYPE; PHLEBOTOMY; PRIORITY JOURNAL; SEX DIFFERENCE; THYROID FUNCTION; THYROID FUNCTION TEST; TRANSFERRIN BLOOD LEVEL; ULTRASOUND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE MANAGEMENT; FEMALE; FERRITINS; HEMOCHROMATOSIS; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; YOUNG ADULT;

EID: 84874367912     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2012.02937.x     Document Type: Article

References (26)

1. Allen K, Gurrin L, Constantine C, Osborne N, Delatycki M, Nicoll A et al. Iron-overload-related disease in HFE hereditary haemochromatosis. N Engl J Med 2008; 358: 221-230.
2. Pietrangelo A. Hereditary haemochromatosis. Annu Rev Nutr 2006; 26: 251-270.
3. Niderau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary haemochromatosis. Gastroenterology 1996; 110: 1107-1119.
4. Steinberg K, Cogswell M, Chang J, Caudill S, McQuillan G, Bowman B et al. Prevalence of C282Y and H63D mutations in the haemochromatosis (HFE) gene in the United States. JAMA 2001; 285: 2216-2222.
5. Gochee P, Powell L, Cullen D, Du Sart D, Rossi E, Olynyk J et al. A population based study of the biochemical and clinical expression of the H63D haemochromatosis mutation. Gastroenterology 2002; 122: 646-651.
6. Moirand R, Jouanolle A, Brissot P, Le Gall J, David V, Deugnier Y. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-over-loaded patients and relatives. Gastroenterology 1999; 116: 372-377.
7. Walsh A, Dixon J, Ramm G, Hewett D, Lincoln D, Anderson G et al. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in haemochromatosis. Clin Gastroenterol Hepatol 2006; 4: 1403-1410.
8. Crawford D, Jazwinska E, Cullen L, Powell L. Expression of HLA-linked haemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998; 114: 1003-1008.
9. Aguilar-Martinez P, Grandchamp B, Cunat S, Cadet E, Blanc F, Nourrit M etal. Iron overload in HFE-C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants. Hematologica 2011; 96: 507-514.
10. Neghina A, Anghel A. Hemochromatosis genotypes and risk of iron overload - a meta analysis. Ann Epidemiol 2011; 21: 1-14.
11. Gurrin LC, Bertalli NA, Dalton GW, Osborne NJ, Constantine CC, McLaren CE etal. HFE C282Y/H63D compound heterozygotes are at low risk of haemochromatosis-related morbidity. Hepatology 2009; 50: 94-101.
12. Cunat S, Giansily-Blaizot M, Bismuth M, Blanc F, Dereure O, Larrey D etal. Global sequencing approach for characterizing the molecular background of hereditary iron disorders. Clin Chem 2007; 53: 2060-2069.
13. Bayard M, Holt J, Boroughs E. Nonalcoholic fatty liver disease. Am Fam Physician 2006; 73: 1961-1968.
14. Brudevold R, Hole T, Hammerstrøm J. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload. Plos ONE 2008; 3: e3547.
15. Bedogni G, Miglioli L, Masutti F, Castiglione A, Crocè LS, Tiribelli C etal. Incidence and natural course of fatty liver in the general population: the Dionysos study. Hepatology 2007; 46: 1387-1391.
16. Farrell G, Chitturi S, Lau G, Sollano J. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-777.
17. Schöniger-Hekele M, Müller C, Polli C, Wrba F, Penner E, Ferenci P. Liver pathology in compound heterozygous patients for haemochromatosis mutations. Liver 2002; 22: 295-301.
18. Morrison E, Brandhagen D, Phatak P, Barton J, Krawitt E, El-Serag H et al. Serum ferritin level predicts advanced hepatic fibrosis amongst US patients with phenotypic haemochromatosis. Ann Intern Med 2003; 138: 627-633.
19. Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams P. Noninvasive prediction of cirrhosis in C282Y linked haemochromatosis. Hepatology 2002; 36: 673-678.
20. Olynyk JK, Hagan SE, Cullen DJ, Beilby J, Whittall DE. Evolution of untreated hereditary haemochromatosis in the Busselton population: a 17-year study. Mayo Clin Proc 2004; 79: 309-313.
21. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ etal. Increased hepatic iron concentration in non-alcoholic steato-hepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-318.
22. Weidong L, Shimomura S, Imanishi H, Iwamoto Y, Ikeda N, Saito M etal. Hemochromatosis with mutation of ferroportin 1 (IREG1) gene. Intern Med 2005; 44: 285-289.
23. Bruce K, Byrne C. The metabolic syndrome: common origins of a multifactorial disorder. Postgrad Med J 2009; 85: 614-621.
24. Lim EM, Rossi E, De Boer WB, Reed W, Jeffrey G. Hepatic iron loading in patients with compound heterozugous HFE mutation. Liver Int 2004; 24: 631-636.
25. Taouli B, Ehman R, Reeder S. Advanved MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol 2009; 193: 14-27.
26. Guyader D, Gandon R, Heautot J, Jouanolle H, Jacquelinet C, Messner M etal. Magnetic resonance imaging and assessment of liver iron content in genetic haemochromatosis. J Hepatol 1992; 15: 3043-08.